Differentiation of 3-Hydroxy-3-methylglutaryl-coenzyme A Reductase Inhibitors by Their Relative Lipophilicity

By Joshi H.N.   Fakes M.G.   Serajuddin A.T.M.  

Pharmacy and Pharmacology Communications, Vol. 5, Iss. 4, 1999-04 ,pp. : 269-271

Pharmaceutical Press

Access to resources Recommend Favorite

3-Hydroxy-3-methylglutaryl coenzyme A reductase inhibitor impairs cell differentiation in cultured adipogenic cells (3T3-L1)

By Nishio E.   Tomiyama K.   Nakata H.   Watanabe Y.  

European Journal of Pharmacology, Vol. 301, Iss. 1, 1996-04 ,pp. : 203-206

Elsevier

Access to resources Recommend Favorite

Therapeutic Potential of 3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase Inhibitors for the Treatment of Retinal and Eye Diseases

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 6, Iss. 4, 2007-08 ,pp. : 282-287

Bentham Science Publishers

Access to resources Recommend Favorite

Metabolism and drug interactions of 3-hydroxy-3-methylglutaryl coenzyme A-reductase inhibitors (statins)

By Igel M.   Sudhop T.   von Bergmann K.  

European Journal of Clinical Pharmacology, Vol. 57, Iss. 5, 2001-08 ,pp. : 357-364

Springer Publishing Company

Access to resources Recommend Favorite

The influence of hydrophilic 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor (pravastatin) on gelatinase activity in vitro

By Kurzepa Jacek   Stryjecka-Zimmer Marta   Szczepańska-Szerej Anna   Kurzepa Joanna  

Pharmaceutical Biology (Formerly International Journal of Pharmacognosy), Vol. 47, Iss. 10, 2009-10 ,pp. : 924-926

Informa Healthcare

Access to resources Recommend Favorite